AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36029336 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (group C)
Number of subjects: 60
Study 33026175 — intervention group
Group type: EXPERIMENTAL
Intervention: 160 IU intranasal insulin (IN-INS)
Number of subjects: 30
Study 33026175 — intervention group
Group type: COMPARATOR
Intervention: Intranasal placebo
Number of subjects: 30
Study 36092515 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA) powder, applied twice a day for 60 days.
Number of subjects: 60
Study 36092515 — intervention group
Group type: COMPARATOR
Intervention: Microcrystalline cellulose powder (placebo), applied twice a day for 60 days.
Number of subjects: 60
Study 32725809 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated lifestyle counselling (IG)
Number of subjects: 1783
Study 32725809 — intervention group
Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 1783
Study 35691288 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual LiFE intervention (n = 156)
Number of subjects: 309
Study 35691288 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based LiFE intervention (n = 153)
Number of subjects: 309
Study 35691288 — intervention group
Group type: COMPARATOR
Intervention: Both LiFE formats (Individual and Group-based)
Number of subjects: 309
Study 35691288 — intervention group
Group type: COMPARATOR
Intervention: Both formats (Individual and Group-based)
Number of subjects: 309
Study 33891798 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal reinforcement (TAR)
Number of subjects: 54
Study 33891798 — intervention group
Group type: COMPARATOR
Intervention: Protective ileostomy (PI)
Number of subjects: 54
Study 32438420 — intervention group
Group type: COMPARATOR
Intervention: Sham interventions (e.g., saline injections into spinal structures, peripheral nerves, cranial surgery, spine surgery)
Number of subjects: 82
Study 32438420 — intervention group
Group type: EXPERIMENTAL
Intervention: Double blinded RCTs
Number of subjects: 82
Study 32438420 — intervention group
Group type: EXPERIMENTAL
Intervention: Single blinded RCTs
Number of subjects: 82
Study 32438420 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreported blinding
Number of subjects: 82
Study 36171147 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages about specific harms and chemicals of VLNCs
Number of subjects: 1763
Study 36171147 — intervention group
Group type: EXPERIMENTAL
Intervention: Messages with information about quitting efficacy
Number of subjects: 1763
Study 33811747 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy diet (3,450 kcal/kg)
Number of subjects: 45
Study 33811747 — intervention group
Group type: COMPARATOR
Intervention: Medium energy diet (3,150 kcal/kg)
Number of subjects: 45
Study 33811747 — intervention group
Group type: COMPARATOR
Intervention: Low energy diet (2,850 kcal/kg)
Number of subjects: 45
Study 36314990 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT: 4x4 minutes at 95% maximal aerobic speed (MAS) with 3 minutes active breaks
Number of subjects: 48
Study 36314990 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT: 8x20 seconds at 150% MAS with 10 seconds passive breaks
Number of subjects: 48
Study 36314990 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT: 10x30 seconds at 175% MAS with 3.5 minutes active breaks
Number of subjects: 48
Study 32205769 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotic treatment (ABT) per PEG protocol (n=78)
Number of subjects: 297
Study 32205769 — intervention group
Group type: EXPERIMENTAL
Intervention: Any ABT (per PEG protocol or clinical indication) (n=115)
Number of subjects: 297
Study 35288018 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PSI-rTMS
Number of subjects: 31
Study 35288018 — intervention group
Group type: COMPARATOR
Intervention: Sham PSI-rTMS
Number of subjects: 31
Study 32706674 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed web-based education and exercise therapy for 6 weeks
Number of subjects: 35
Study 32706674 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led education and exercise therapy (face-to-face or telerehabilitation) for 12 weeks
Number of subjects: 35
Study 32706674 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face physiotherapy
Number of subjects: 35
Study 32706674 — intervention group
Group type: COMPARATOR
Intervention: Telerehabilitation physiotherapy
Number of subjects: 35
Study 33782552 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk APOL1 variants intervention for hypertension management
Number of subjects: 2
Study 33782552 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacogenetic testing for medications managing acute and chronic pain and depression
Number of subjects: 2
Study 36028916 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior cervical discectomy with arthroplasty (ACDA)
Number of subjects: 0
Study 36028916 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy with fusion (ACDF)
Number of subjects: 0
Study 36028916 — intervention group
Group type: EXPERIMENTAL
Intervention: ACDA
Number of subjects: 0
Study 36028916 — intervention group
Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 0
Study 33509394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (minor: ≥3 and <5 g/dl) without overt bleeding
Number of subjects: 7781
Study 33509394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (major: ≥5 g/dl) without overt bleeding
Number of subjects: 7781
Study 33509394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (minor: ≥3 and <5 g/dl) with overt bleeding
Number of subjects: 7781
Study 33509394 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoglobin drop (major: ≥5 g/dl) with overt bleeding
Number of subjects: 7781
Study 33112644 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔΔP (change in driving pressure) after ventilator adjustments
Number of subjects: 968
Study 33112644 — intervention group
Group type: EXPERIMENTAL
Intervention: ΔPaO2/FIO2 (change in oxygenation) after ventilator adjustments
Number of subjects: 968
Study 35577476 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic lidocaine (1.5 mg/kg bolus, followed by 1.5 mg/kg/hour infusion until the end of surgery)
Number of subjects: 1020
Study 35577476 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline, identical volumes and rates)
Number of subjects: 1020
Study 35577476 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic lidocaine
Number of subjects: 1020
Study 33615769 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric toothbrush/irrigator combination (test)
Number of subjects: 60
Study 33615769 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush alone (control)
Number of subjects: 60
Study 34353864 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin 20g
Number of subjects: 19
Study 34353864 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin 20g + Psyllium 20g
Number of subjects: 19
Study 34353864 — intervention group
Group type: EXPERIMENTAL
Intervention: Psyllium 20g
Number of subjects: 19
Study 34353864 — intervention group
Group type: COMPARATOR
Intervention: Dextrose 20g (placebo)
Number of subjects: 19
Study 33470941 — intervention group
Group type: EXPERIMENTAL
Intervention: Habits Heart App (intervention group)
Number of subjects: 28
Study 33470941 — intervention group
Group type: COMPARATOR
Intervention: Control group (paper education material)
Number of subjects: 28
Study 32807241 — intervention group
Group type: EXPERIMENTAL
Intervention: LMWH + steroid group
Number of subjects: 210
Study 32807241 — intervention group
Group type: EXPERIMENTAL
Intervention: UFH + steroid group
Number of subjects: 210
Study 32807241 — intervention group
Group type: COMPARATOR
Intervention: LMWH group
Number of subjects: 210
Study 35257687 — intervention group
Group type: EXPERIMENTAL
Intervention: Particulate matter with aerodynamic diameter ≤10 μm (PM10)
Number of subjects: 1425
Study 35257687 — intervention group
Group type: EXPERIMENTAL
Intervention: Particulate matter with aerodynamic diameter ≤2.5 μm (PM2.5)
Number of subjects: 1425
Study 35257687 — intervention group
Group type: EXPERIMENTAL
Intervention: Black carbon (BC)
Number of subjects: 1425
Study 35257687 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in carotid intima-media thickness (cIMT)
Number of subjects: 1425
Study 34204694 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Tap Dance Program (MTD)
Number of subjects: 44
Study 34204694 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 44
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully engaged parents
Number of subjects: 214
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially engaged parents
Number of subjects: 214
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Independently engaged parents
Number of subjects: 214
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully engaged children
Number of subjects: 214
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially engaged children
Number of subjects: 214
Study 35731547 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabblers
Number of subjects: 214
Study 35213594 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 68
Study 35213594 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 33285695 — intervention group
Group type: EXPERIMENTAL
Intervention: OxyContin with standardized nursing care
Number of subjects: 90
Study 33285695 — intervention group
Group type: COMPARATOR
Intervention: OxyContin
Number of subjects: 90
Study 36102440 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face aerobic exercise
Number of subjects: 25
Study 36102440 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 25
Study 33499889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough severity in women
Number of subjects: 180
Study 33499889 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough severity in men
Number of subjects: 180
Study 33499889 — intervention group
Group type: EXPERIMENTAL
Intervention: CQLQ total score for women
Number of subjects: 180
Study 33499889 — intervention group
Group type: COMPARATOR
Intervention: CQLQ total score for men
Number of subjects: 180
Study 33499889 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender modification effect
Number of subjects: 180
Study 36206400 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab (1, 4, or 10 mg/kg intravenous or 200 mg subcutaneous) plus standard therapy
Number of subjects: 4170
Study 36206400 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 4170
Study 36206400 — intervention group
Group type: EXPERIMENTAL
Intervention: Belimumab
Number of subjects: 4170
Study 36206400 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4170
Study 32131611 — intervention group
Group type: EXPERIMENTAL
Intervention: 81 mg low-dose aspirin (COX-1 inhibitor) for 2 weeks
Number of subjects: 45
Study 32131611 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 45
Study 35807781 — intervention group
Group type: EXPERIMENTAL
Intervention: Farm-to-School Nutrition and Gardening Intervention
Number of subjects: 193
Study 35807781 — intervention group
Group type: COMPARATOR
Intervention: Wait-list Control
Number of subjects: 193
Study 33822767 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 113450
Study 33822767 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin/alfuzosin/doxazosin
Number of subjects: 113450
Study 33822767 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 113450
Study 34041705 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver depressive symptoms (measured by Center for Epidemiologic Studies Depression scale)
Number of subjects: 208
Study 34041705 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate asthma at baseline
Number of subjects: 208
Study 34041705 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe asthma at baseline
Number of subjects: 208
Study 34041705 — intervention group
Group type: EXPERIMENTAL
Intervention: Household income < $20,000 per year
Number of subjects: 208
Study 34041705 — intervention group
Group type: EXPERIMENTAL
Intervention: Fall season
Number of subjects: 208
Study 32762319 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM-IV PTSD Checklist
Number of subjects: 128
Study 32762319 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM-5 PTSD Checklist
Number of subjects: 128
Study 32762319 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended version of PTSD Checklist
Number of subjects: 128
Study 33492500 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydrocortisone sodium succinate and aluminum phosphate gel (OHA)
Number of subjects: 63
Study 33492500 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic loco-regional triamcinolone acetonide injection (ETI) plus oral prednisone
Number of subjects: 63
Study 33492500 — intervention group
Group type: EXPERIMENTAL
Intervention: OHA
Number of subjects: 63
Study 33492500 — intervention group
Group type: COMPARATOR
Intervention: ETI plus oral prednisone
Number of subjects: 63
Study 33492500 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal defect > 11/12 circumference
Number of subjects: 63
Study 34455688 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehospital antiplatelet therapy
Number of subjects: 17347
Study 34455688 — intervention group
Group type: COMPARATOR
Intervention: Non-antiplatelet therapy
Number of subjects: 17347
Study 35791089 — intervention group
Group type: EXPERIMENTAL
Intervention: Infuza
Number of subjects: 251
Study 35791089 — intervention group
Group type: EXPERIMENTAL
Intervention: Kulzam
Number of subjects: 251
Study 35791089 — intervention group
Group type: EXPERIMENTAL
Intervention: Infuza & Kulzam
Number of subjects: 251
Study 35791089 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 251
Study 35791089 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 251
Study 32372486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate treatment (various preparations and doses)
Number of subjects: 240
Study 32372486 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate treatment (pooled active treatment groups)
Number of subjects: 240
Study 32372486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 35840446 — intervention group
Group type: EXPERIMENTAL
Intervention: Densah burs
Number of subjects: 12
Study 35840446 — intervention group
Group type: COMPARATOR
Intervention: Osteotome
Number of subjects: 12
Study 34735046 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI
Number of subjects: 1500
Study 34735046 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 1500
Study 32621630 — intervention group
Group type: EXPERIMENTAL
Intervention: Couple-based meditation (CBM)
Number of subjects: 75
Study 32621630 — intervention group
Group type: COMPARATOR
Intervention: Supportive-expressive (SE)
Number of subjects: 75
Study 32621630 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 75
Study 35860190 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenling Chengqi decoction combined with routine treatment for 7 days
Number of subjects: 160
Study 35860190 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (control group)
Number of subjects: 160
Study 33840150 — intervention group
Group type: EXPERIMENTAL
Intervention: EW nebuliser
Number of subjects: 15
Study 33840150 — intervention group
Group type: COMPARATOR
Intervention: DV 646 nebuliser
Number of subjects: 15
Study 32053417 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) treadmill running with 60% body weight
Number of subjects: 20
Study 32053417 — intervention group
Group type: COMPARATOR
Intervention: Lower-body positive pressure (LBPP) treadmill running with 100% body weight
Number of subjects: 20
Study 32053417 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body positive pressure (LBPP) treadmill running
Number of subjects: 20
Study 36123103 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge design of electronic point-of-care randomisation prompt with liberal magnesium supplementation
Number of subjects: 50
Study 36123103 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudge design of electronic point-of-care randomisation prompt with restrictive magnesium supplementation
Number of subjects: 50
Study 36123103 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference design of electronic point-of-care randomisation prompt with liberal magnesium supplementation
Number of subjects: 50
Study 36123103 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference design of electronic point-of-care randomisation prompt with restrictive magnesium supplementation
Number of subjects: 50
Study 36123103 — intervention group
Group type: COMPARATOR
Intervention: Nudge and Preference designs
Number of subjects: 50
Study 36123103 — intervention group
Group type: COMPARATOR
Intervention: Pre-emptive and opt-out consent models
Number of subjects: 50
Study 33105277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous anesthesia of 20% sevoflurane emulsion
Number of subjects: 6
Study 33105277 — intervention group
Group type: COMPARATOR
Intervention: Inhalation anesthesia of sevoflurane
Number of subjects: 6
Study 35960908 — intervention group
Group type: EXPERIMENTAL
Intervention: Elotuzumab combined with pomalidomide/dexamethasone (EPd)
Number of subjects: 117
Study 35960908 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide/dexamethasone (Pd)
Number of subjects: 117
Study 33580663 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Failure Exercise and Resistance Training (HEART) Camp
Number of subjects: 204
Study 32516301 — intervention group
Group type: EXPERIMENTAL
Intervention: TPAD training with visual feedback and task-specific overground training
Number of subjects: 11
Study 32516301 — intervention group
Group type: EXPERIMENTAL
Intervention: TPAD training
Number of subjects: 11
Study 33870873 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomics training intervention
Number of subjects: 0
Study 33207094 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorlatinib
Number of subjects: 296
Study 33207094 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 296
Study 35112178 — intervention group
Group type: COMPARATOR
Intervention: Local periarticular infiltration anaesthesia (LIA) with 60 ml of ropivacaine 0.5% and 1 ml of dexmedetomidine (100 µg ml‐1)
Number of subjects: 50
Study 35112178 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided regional anaesthesia (USRA) with two single-shot femoral and popliteal blocks, each with 15 ml of ropivacaine 0.5% and 0.5 ml of dexmedetomidine
Number of subjects: 50
Study 33910879 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean Red ginseng
Number of subjects: 26
Study 33910879 — intervention group
Group type: COMPARATOR
Intervention: Control (no ginseng)
Number of subjects: 26
Study 33784802 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 10 mg
Number of subjects: 0
Study 33784802 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 2.5 mg
Number of subjects: 0
Study 33784802 — intervention group
Group type: EXPERIMENTAL
Intervention: IV dexamethasone 5 mg
Number of subjects: 0
Study 33784802 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study 33784802 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 32682696 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 524
Study 32682696 — intervention group
Group type: EXPERIMENTAL
Intervention: eCDSS
Number of subjects: 524
Study 32682696 — intervention group
Group type: EXPERIMENTAL
Intervention: eCDSS-PLUS
Number of subjects: 524
Study 35439347 — intervention group
Group type: EXPERIMENTAL
Intervention: Rezafungin 10 mg single subcutaneous dose
Number of subjects: 50
Study 35439347 — intervention group
Group type: EXPERIMENTAL
Intervention: Rezafungin (various doses: 1, 10, 30, 60, 100, or 200 mg)
Number of subjects: 50
Study 35439347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 33706186 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of perindopril, indapamide, and amlodipine
Number of subjects: 0
Study 33706186 — intervention group
Group type: EXPERIMENTAL
Intervention: UPLC-MS/MS method for quantification
Number of subjects: 0
Study 33706186 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction recovery of perindopril, perindoprilat, and indapamide
Number of subjects: 0
Study 33706186 — intervention group
Group type: EXPERIMENTAL
Intervention: Stability of analytes
Number of subjects: 0
Study 33706186 — intervention group
Group type: EXPERIMENTAL
Intervention: UPLC-MS/MS method
Number of subjects: 0
Study 35283313 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 followed by a mRNA vaccine
Number of subjects: 6544
Study 35283313 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >= 75 years
Number of subjects: 6544
Study 34812138 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicompartmental knee replacement
Number of subjects: 57938
Study 34812138 — intervention group
Group type: COMPARATOR
Intervention: Total knee replacement
Number of subjects: 57938
Study 32329737 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-based messaging intervention (mHealth)
Number of subjects: 59
Study 36060926 — intervention group
Group type: EXPERIMENTAL
Intervention: rh‐EGF combined with PVI
Number of subjects: 105
Study 36060926 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control group)
Number of subjects: 105
Study 33337904 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological behaviour management programme (including symbolic modelling, tell‐show‐do, positive reinforcement, distraction) during the second treatment
Number of subjects: 48
Study 33337904 — intervention group
Group type: COMPARATOR
Intervention: Watching cartoon animations during the first treatment and control group during the second treatment
Number of subjects: 48
Study 35293006 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐VCd (daratumumab, bortezomib, cyclophosphamide, and dexamethasone)
Number of subjects: 0
Study 35293006 — intervention group
Group type: COMPARATOR
Intervention: VCd (bortezomib, cyclophosphamide, and dexamethasone)
Number of subjects: 0
Study 35293006 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐VCd followed by daratumumab monotherapy
Number of subjects: 0